Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr;61(2):179-192.
doi: 10.1007/s11262-024-02128-w. Epub 2024 Dec 16.

Effect of thymidine kinase-deficiency (∆ORF38) on neuropathogenicity of equine herpesvirus-1 in the mouse model and expression of neighboring genes

Affiliations

Effect of thymidine kinase-deficiency (∆ORF38) on neuropathogenicity of equine herpesvirus-1 in the mouse model and expression of neighboring genes

Samy Kasem et al. Virus Genes. 2025 Apr.

Abstract

Previous studies showed that deletion of the viral thymidine kinase (TK) gene in several alphaherpesviruses including EHV-1 reduced their virulence. Previously, we found that deletion of ORF37, which is located head-to-head with TK, decreased EHV-1 virulence in mice but did not affect the expression of TK mRNA. Therefore, deletion of ORF38 might also affect virulence by partially deleting the ORF37 promoter. To investigate the role of the TK gene-encoding region in the pathogenesis of EHV-1 as well as the expression of ORF37, we generated a TK deletion mutant by using a bacterial artificial chromosome carrying the neuropathogenic strain Ab4p. Deletion of TK increased the transcription of ORF37, did not cause any neurological disorders in CBA/N1 mice, and its growth in cultured neural cells was impaired. These results suggest deletion of ORF38 does not affect the ORF37 promoter and confirm that TK plays an important role in the neuropathogenicity of EHV-1.

Keywords: EHV-1; Equine; Herpesviridae; ORF37; ORF38; Thymidine kinase (TK).

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflict of interest: The authors declare no competing interests.

Similar articles

References

    1. Allen GP, Bryans JT (1986) Molecular epizootiology, pathogenesis, and prophylaxis of equine herpesvirus-1 infections. Prog Vet Microbiol Immunol 2:78–144 - PubMed
    1. Carroll CL, Westbury HA (1985) Isolation of equine herpesvirus 1 from the brain of a horse affected with paresis. Aust Vet J 62(10):345–346. https://doi.org/10.1111/j.1751-0813.1985.tb07660.x - DOI - PubMed
    1. Crabb BS, Studdert MJ (1995) Equine herpesviruses 4 (equine rhinopneumonitis virus) and 1 (equine abortion virus). Adv Virus Res 45:153–190. https://doi.org/10.1016/s0065-3527(08)60060-3 - DOI - PubMed
    1. Soboll-Hussey G, Dorman DC, Burgess BA, Goehring L, Gross P, Neinast C et al (2024) Relationship between equine herpesvirus-1 viremia and abortion or equine herpesvirus myeloencephalopathy in domesticated horses: a systematic review. J Vet Intern Med 38(3):1872–1891. https://doi.org/10.1111/jvim.16948 - DOI - PubMed
    1. Nugent J, Birch-Machin I, Smith KC, Mumford JA, Swann Z, Newton JR et al (2006) Analysis of equid herpesvirus 1 strain variation reveals a point mutation of the DNA polymerase strongly associated with neuropathogenic versus nonneuropathogenic disease outbreaks. J Virol 80(8):4047–4060. https://doi.org/10.1128/jvi.80.8.4047-4060.2006 - DOI - PubMed - PMC

LinkOut - more resources